Akcea Therapeutics (AKCA) Tops Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St treads water as chips rise, megacaps fall ahead of Fed, Big Tech earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Akcea Therapeutics, Inc. (AKCA) PT Raised to $47 at BMO Capital
November 6, 2018 3:52 AM ESTBMO Capital analyst Do Kim raised the price target on Akcea Therapeutics, Inc. (NASDAQ: AKCA) to $47.00 (from $42.00) while maintaining a Outperform rating.
... More


